Shivalik Evergreen 120 Capsules Liver & Kidney Support

68

LIVER

Liver support and detox supplement Shivalik Evergreen

Shivalik Evergreen is a natural combination of herbs that has been found to support liver health and your body’s essential detoxification processes. It strengthens the liver and revives liver cells, making it the best choice for all types of liver problems. It protects the liver from damages caused by inflammation, oxidation, alcoholism, diabetes, and other liver disorders.

Hepatitis and Cirrhosis are two diseases that can badly damage your liver. Hepatitis is an inflammation of the liver brought on by excessive intake of alcohol. Cirrhosis is a serious disease that changes the structure of the liver so that it cannot function properly. In Cirrhosis less blood flows through the liver and the toxins that are normally eliminated can now poison the body. About 20% of heavy drinkers eventually develop Cirrhosis and Alcoholic Hepatitis.: Hepatitis, an inflammation of the liver brought on by excessive alcohol consumption, and Cirrhosis, a serious condition that alters the structure of the liver and impairs its ability to function, affect about 20% of heavy drinkers over time.

Shivalik Evergreen can restore damaged liver and regenerate it, which is good news because even a damaged liver retains an amazing capacity for self-regeneration.

The benefits of Shivalik Evergreen include:

  • drunken liver
  • Diabetes causes liver damage
  • liver dysfunction in general
  • Jaundice
  • fatty liver, enlarged liver, and liver cirrhosis
  • Having trouble eating and feeling sick

Dosage:

Three times daily, take one capsule after meals.

It uses only the highest-quality, 100% safest ingredients, and the company is GMP, HALAL, HACCP, ISO 9001:2015, and ISO 22000:2005 certified. For Best Results, use it for at least 3 months.

Attributes
BrandShivalik Herbals
Container TypeBottle Packing.
Shelf Life3 years from date of manufacturing.
Remedy TypeAyurvedic
Country of OriginIndia
Form FactorCapsule
Price₹ 830

Comments are closed.